Literature DB >> 25687802

Determination and pharmacokinetic study of two triterpenoid saponins in rat plasma after oral administration of the extract of Aralia elata leaves by UHPLC-ESI-MS/MS.

Zhibin Wang1, Qiong Wu2, Yonghai Meng2, Yichun Sun2, Qi Wang2, Chunjuan Yang3, Qiuhong Wang2, Bingyou Yang2, Haixue Kuang4.   

Abstract

Aralia elata (Miq.) Seems (A. elata) grow in Northeast China and the total saponins of A. elata is used to auxiliary treatment for the acute hepatitis, chronic hepatitis and the transaminase on the high side. Aralia-saponinV and Aralia-saponinVI are the major bioactive saponins in A. elata leaves. A selective and sensitive UHPLC-MS/MS method was developed and validated for the determination and pharmacokinetic study of Aralia-saponinV and Aralia-saponinVI indwelling the extract in rat plasma in this article. The sample pretreatment involved a one-step extraction of 0.2mL plasma with methanol. Shengmaxinside C was used as internal standard (I.S.). The separation was carried out on an Agilent SB-C18 column (1.8μm, 50mm×2.1mm) at 30°C with a mobile phase of acetonitrile-5mM ammonium acetate (90:10, v/v) at a flow rate of 0.2mL/min. The detection was performed on a triple quadrupole tandem mass spectrometer by multiple reaction monitoring (MRM) mode via electrospray ionization (ESI) source operating in the negative ionization mode. The optimized mass transition ion-pairs (m/z) monitored for Aralia-saponinV, Aralia-saponinVI and I.S. were 1103.2/941.2, 1119.2/957.0 and 707.0/647.1, respectively. The current UHPLC-MS/MS assay method was validated for linearity, intra-day and inter-day precisions, accuracy, extraction recovery and stability, and it was suitable for the pharmacokinetic studies of the two saponins after oral administration of extract of A. elata leaves. The lower limits of quantification were 5.70ng/mL for Aralia-saponinV and 6.15ng/mL for Aralia-saponinVI. Intra-day and inter-day precisions were less than 7.4% and the accuracy range was from 1.19% to 8.60%. The mean extraction recoveries of analytes and I.S. from rat plasma were all more than 89.5%. This paper described a simple, sensitive and validated UHPLC-MS/MS method for simultaneous determination of Aralia-saponinV and Aralia-saponinVI in rat plasma after oral administration of the extract of A. elata leaves, and investigated on their pharmacokinetic studies as well.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aralia elata (Miq.) Seem; Aralia-saponinV; Aralia-saponinVI; Pharmacokinetics; UHPLC–ESI–MS/MS

Mesh:

Substances:

Year:  2015        PMID: 25687802     DOI: 10.1016/j.jchromb.2015.01.036

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  4 in total

Review 1.  Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases.

Authors:  Alexander G Panossian; Thomas Efferth; Alexander N Shikov; Olga N Pozharitskaya; Kenny Kuchta; Pulok K Mukherjee; Subhadip Banerjee; Michael Heinrich; Wanying Wu; De-An Guo; Hildebert Wagner
Journal:  Med Res Rev       Date:  2020-10-25       Impact factor: 12.944

2.  The development and validation of an HPLC-MS/MS method for the determination of eriocitrin in rat plasma and its application to a pharmacokinetic study.

Authors:  Luya Li; Rui Feng; Xue Feng; Yuting Chen; Xin Liu; Wenjing Sun; Lantong Zhang
Journal:  RSC Adv       Date:  2020-03-12       Impact factor: 4.036

3.  Assessment of a developed HPLC-MS/MS approach for determining plasma eupatorin in rats and its application in pharmacokinetics analysis.

Authors:  Rui Feng; Luya Li; Xiaowei Zhang; Yuqian Zhang; Yuting Chen; Xue Feng; Lantong Zhang; Guohua Zhang
Journal:  RSC Adv       Date:  2020-08-28       Impact factor: 4.036

4.  Comparison of chemical composition in the buds of Aralia elata from different geographical origins of China.

Authors:  Mingming Qi; Xiaoyu Hua; Xiaoyuan Peng; Xiufeng Yan; Jixiang Lin
Journal:  R Soc Open Sci       Date:  2018-08-15       Impact factor: 2.963

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.